Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

High-potency omega-3 (EPA/DHA, SPM precursors)

High-Concentrate Omega-3 (EPA / DHA) · also known as Fish oil, rTG fish oil, Pro-resolving mediator precursors

EPA and DHA at 2–4 g/day lower triglycerides by about 20–30%, a finding supported by many randomized trials. They are also precursors of specialized pro-resolving mediators (SPMs). However, changes in the different pro-resolving mediators in humans are inconsistent, and the real effect on inflammation resolution is still unclear.

Typical dose: 1500–3000 mg/day of pure EPA + DHA, taken with a high-fat meal
Absorption and forms: How much better the re-esterified triglyceride (rTG) form is absorbed than the ethyl ester (EE) form depends on the meal, the dose and the study design, so it should not be summed up as a fixed percentage. How much fishy reflux people get also varies from person to person. Fish oil oxidizes and goes rancid easily; when buying and storing it, you can use the product’s TOTOX (oxidation) value as a guide.

Clinical uses and human evidence

High triglycerides

BeneficialGrade A · Strong evidence
Studies (1)
  1. Wang 2023 · J Am Heart Assoc · Meta-analysis · n=72598 — Association Between Omega-3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose-Response Meta-Analysis of Randomized Controlled Trials

High blood pressure

BeneficialGrade A · Strong evidence
Studies (1)
  1. Zhang 2022 · J Am Heart Assoc · Meta-analysis · n=4973 — Omega-3 Polyunsaturated Fatty Acids Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials

Heart attack, stroke and other cardiovascular events

Mixed resultsGrade A · Strong evidence
Studies (3)
  1. Nicholls 2020 · JAMA · RCT · n=13078 — Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial
  2. Kalstad 2021 · Circulation · RCT · n=1027 — Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled Trial
  3. Abdelhamid 2020 · Cochrane Database Syst Rev · Meta-analysis · n=162796 — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease

High LDL cholesterol

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Wang 2023 · J Am Heart Assoc · Meta-analysis · n=72598 — Association Between Omega-3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose-Response Meta-Analysis of Randomized Controlled Trials

Low mood

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Norouziasl 2024 · Br J Nutr · Meta-analysis — Efficacy and safety of n-3 fatty acids supplementation on depression: a systematic review and dose-response meta-analysis of randomised controlled trials

Inflammation markers (such as CRP)

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Khabir 2026 · Crit Rev Food Sci Nutr · Meta-analysis — Role of the EPA: DHA dosing ratio in omega-3 supplements on blood fatty acid profiles and inflammation: a systematic review and meta-analysis

Falls in older adults

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Bischoff-Ferrari 2022 · Am J Clin Nutr · RCT · n=2157 — Effects of vitamin D, omega-3 fatty acids, and a simple home strength exercise program on fall prevention: the DO-HEALTH randomized clinical trial

Age-related cognitive decline

No benefitGrade A · Strong evidence
Studies (1)
  1. Brainard 2020 · J Am Med Dir Assoc · Meta-analysis · n=49757 — Omega-3, Omega-6, and Polyunsaturated Fat for Cognition: Systematic Review and Meta-analysis of Randomized Trials

Blood sugar and insulin resistance

No benefitGrade A · Strong evidence
Studies (1)
  1. Brown 2019 · BMJ · Meta-analysis — Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials

All-cause mortality risk

No benefitGrade A · Strong evidence
Studies (2)
  1. Abdelhamid 2020 · Cochrane Database Syst Rev · Meta-analysis · n=162796 — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
  2. Nicholls 2020 · JAMA · RCT · n=13078 — Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial

Macular and vision protection

No benefitGrade B · Moderate evidence
Studies (1)
  1. Age-Related Eye Disease Study 2 Research Group 2013 · JAMA · RCT · n=4203 — Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial

Mechanisms of action

Pro-resolving mediator precursors and active inflammation resolution (SPMs)

★★★★☆Mechanism evidence: grade A

EPA is a precursor of E-series resolvins, and DHA is a precursor of D-series resolvins, protectins and other mediators. Both serve as metabolic substrates for inflammation-resolving mediators. Randomized human studies have detected changes in some pro-resolving lipid mediators, but these changes, and their effect on inflammation resolution, are not consistent from one mediator to another.

References (2)
  1. Norris et al. 2018 · Human randomized study with lipidomic validation: omega-3 supplementation was followed by changes in some pro-resolving lipid mediator clusters
  2. Mas et al. 2016 · Randomized trial in patients with chronic kidney disease: after supplementation, some resolvin pathway precursors rose, but responses of the mature mediators were not consistent

Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription

★★☆☆☆Mechanism evidence: grade BSecondary target

Omega-3 can modulate the FFAR4 receptor and downstream inflammatory signaling. Small human studies measured changes in the upstream receptor and related genes. However, the full chain from GPR120 to NF-κB inhibition has not been shown in humans, and whether NF-κB nuclear translocation is suppressed has not been directly confirmed.

References (2)
  1. Reyes-Pérez et al. 2025 · Small human randomized trial: FFAR4 activation in peripheral blood cells and some changes in IKKβ gene expression were observed
  2. Naeini et al. 2020 · Human randomized trial: no significant difference in NF-κB mRNA between the DHA-rich fish oil group and the control group

Autonomic balance and vagal tone

★★☆☆☆Mechanism evidence: grade BSecondary target

A meta-analysis of randomized trials found that fish oil slightly raised the high-frequency component of heart rate variability, which reflects vagal activity, but did not change RMSSD. A trial in overweight adults taking about 2 g/day of EPA+DHA was positive, while a trial in dialysis patients was negative. Taken together, the effect is small.

References (3)
  1. Xin 2013 · Am J Clin Nutr · Meta-analysis · n=692 — Short-term effects of fish-oil supplementation on heart rate variability in humans: a meta-analysis of randomized controlled trials
  2. Ninio 2008 · Br J Nutr · RCT · n=65 — Docosahexaenoic acid-rich fish oil improves heart rate variability and heart rate responses to exercise in overweight adults
  3. Rantanen 2018 · Nutrients · RCT · n=112 — Effects of Marine n-3 Polyunsaturated Fatty Acids on Heart Rate Variability and Heart Rate in Patients on Chronic Dialysis: A Randomized Controlled Trial

Safety and drug interactions

High doses (more than 4 g/day) have mild antiplatelet activity. Whether to stop before major surgery should be decided by a doctor based on bleeding risk and the specific operation, since not all surgeries require stopping it. People taking anticoagulants need monitoring, and people on high-dose pure EPA should also be assessed before surgery. Randomized trials of high-dose omega-3 have found an increased risk of atrial fibrillation, so people taking it should review both their dose and their own cardiovascular risk.

Additive bleeding risk

At more than 3 g/day it can mildly inhibit platelet aggregation. Each of these has a mild antiplatelet or fibrinolytic effect. Alone, the effect is usually small, but when several are combined, the tendency to bleed becomes more noticeable. Stop them 1–2 weeks before surgery or a tooth extraction, and watch for gum bleeding or more bruising.

Related lab tests

Lipid panel Recheck while taking

When fish oil is used to help lower triglycerides, recheck the lipid panel after about 2 months to see the effect. The evidence for high-dose prescription-strength fish oil (4 g/day) cannot be applied directly to ordinary doses.

Open in the interactive app ›